Taysha Gene Therapies, Inc. (TSHA)
Nasdaq: TSHA · Biological Products, (No Diagnostic Substances) · Dallas, TX · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 19, 2026 | Feb 26, 2025 | Mar 19, 2024 | Mar 28, 2023 | Mar 31, 2022 | Mar 3, 2021 |
| Revenue | 9,773 | 8,333 | 15,451 | 2,502 | · | · |
| Research and development | 86,403 | 66,001 | 56,778 | 91,169 | 131,943 | 31,893 |
| General and administrative | 33,868 | 28,953 | 30,047 | 37,360 | 41,324 | 11,109 |
| Total operating expenses | 120,271 | 99,792 | 87,890 | 164,949 | 173,267 | 43,002 |
| Operating income | -110,498 | -91,459 | -72,439 | -162,447 | -173,267 | -43,002 |
| Interest expense | 63 | 102 | 4,998 | 3,798 | 1,428 | 28 |
| Interest and investment income | 9,224 | 6,940 | 3,572 | · | · | · |
| Interest income (expense), net | · | · | 3,572 | 249 | 172 | 49 |
| Other income (expense), net | -291 | -110 | -47 | -18 | · | · |
| Total non-operating income (expense) | 1,503 | 2,161 | -39,127 | -3,567 | -1,256 | -17,009 |
| Income tax expense | 0 | 0 | 0 | 0 | · | 0 |
| Net income including non-controlling interests | -108,995 | -89,298 | -111,566 | -166,014 | -174,523 | -60,011 |
| Net income | -108,995 | -89,298 | -111,566 | -166,014 | -174,523 | -60,011 |
| Net income to common shareholders | -108,995 | -89,298 | -111,566 | -166,014 | -174,523 | -60,011 |
| Earnings per share, basic | -0.34 | -0.36 | -0.96 | -3.78 | -4.64 | · |
| Earnings per share, diluted | -0.34 | -0.36 | -0.96 | -3.78 | -4.64 | · |
| Earnings per share, basic and diluted | · | · | · | · | -4.64 | -3.40 |
| Weighted average shares, basic | 319,711,972 | 250,134,421 | 116,121,482 | 43,952,015 | 37,650,566 | · |
| Weighted average shares, diluted | 319,711,972 | 250,134,421 | 116,121,482 | 43,952,015 | 37,650,566 | · |
| Weighted average shares, basic and diluted | · | · | · | · | 37,650,566 | 17,665,683 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted